2016
DOI: 10.3791/54458
|View full text |Cite
|
Sign up to set email alerts
|

Directed Protein Packaging within Outer Membrane Vesicles from <em>Escherichia coli</em>: Design, Production and Purification

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 30 publications
0
11
0
Order By: Relevance
“…On the basis of the previous studies (Alves, Turner, & Walper, 2016;Ho, Wu, Chang, & Pan, 2011;Pollak, Delpino, Fossati, & Baldi, 2012;Rider, Hurwitz, & Meckes, 2016;Thery, Amigorena, Raposo, & Clayton, 2006;Wieser et al, 2014), the OMVs extraction and purification methods were as follows:…”
Section: Extraction and Purification Of Omvs In Faecesmentioning
confidence: 99%
“…On the basis of the previous studies (Alves, Turner, & Walper, 2016;Ho, Wu, Chang, & Pan, 2011;Pollak, Delpino, Fossati, & Baldi, 2012;Rider, Hurwitz, & Meckes, 2016;Thery, Amigorena, Raposo, & Clayton, 2006;Wieser et al, 2014), the OMVs extraction and purification methods were as follows:…”
Section: Extraction and Purification Of Omvs In Faecesmentioning
confidence: 99%
“…MVs protect their encased cargo from degradation by nucleases [ 29 , 65 ] and proteases [ 66 , 67 , 68 , 69 ]. MVs have been shown to retain enzymatic activity and antigenicity over long-term storage at 4 °C [ 70 , 71 ], as well as short exposure to elevated temperatures. A study has shown that an enzyme, phosphotriesterase (PTE) packaged into E. coli MVs retained enzymatic activity over 100-fold greater than free PTE when subject to elevated temperatures (37 °C for 14 days), and multiple freeze-thaw cycles [ 66 ].…”
Section: Advantages Of Mvs In Therapeutic Applicationsmentioning
confidence: 99%
“…Genetic manipulation of the parent bacteria can refine the functionality of MVs, for instance it allows directed packaging of recombinant epitopes, inclusion of signal molecules for cell-specific targeting or exclusion of undesired and toxic MV components such as LPS [ 56 , 76 , 107 ]. This relative ease of biomanipulation is leading to the development of unique recombinant MV therapies [ 70 ].…”
Section: Bioengineered Mvsmentioning
confidence: 99%
See 2 more Smart Citations